Betacor Tablets
PDF Leaflet Revision Date: 27 October 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Management of mild to moderate essential hypertension and angina pectoris.
Dosage (summary)
5 mg once daily, may increase to 10 mg or 20 mg based on individual response.
Special Populations
- Elderly
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy; not recommended during breastfeeding.
Key Drug Interactions
- Calcium antagonists
- Centrally acting antihypertensives
- Insulin and oral antidiabetics
Contraindications
- Hypersensitivity to bisoprolol
- Acute heart failure
- Cardiogenic shock
- AV block
- Severe bronchial asthma
Common side effects
- Dizziness
- Headache
- Fatigue
- Hypotension
Counselling Points
- Take in the morning with liquid
- Do not stop abruptly
- Monitor for dizziness or fatigue
Serious warnings
- Abrupt withdrawal may cause acute deterioration
- Caution in patients with diabetes or asthma
Important Disclaimer
The Betacor Tablets professional information leaflet below is the property of Merck and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
